tradingkey.logo

Vertex Pharmaceuticals Posts Q1 Adjusted EPS Of $4.06

ReutersMay 5, 2025 9:55 PM

- Vertex Pharmaceuticals Inc VRTX.O:

  • VERTEX PHARMACEUTICALS Q1 ADJUSTED EPS $4.06 VERSUS IBES ESTIMATE $4.32

  • VERTEX PHARMACEUTICALS Q1 TOTAL REVENUE $2.77 BILLION VERSUS IBES ESTIMATE $2.85 BILLION

  • VERTEX PHARMACEUTICALS OUTLOOK 2025 TOTAL REVENUE $11.85 BILLION TO $12.0 BILLION VERSUS IBES ESTIMATE OF $11.97 BILLION

  • VERTEX PHARMACEUTICALS: 2025 GUIDANCE INCLUDES AN IMMATERIAL COST IMPACT FROM TARIFFS

  • VERTEX PHARMACEUTICALS: INTANGIBLE ASSET IMPAIRMENT CHARGE OF $379.0 MILLION ASSOCIATED WITH VX-264 IN Q1

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI